Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

Winter 1997

Volume 3, Issue 4

Pages fmi–fmi, 249–325

  1. Masthead

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Masthead (page fmi)

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030401

  2. Original Contributions

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Length and type of recurrent ileitis after ileal resection correlate with presurgical features in Crohn's disease (pages 249–253)

      Dr. Geert D'Haens, Dr. Filip Baert, Arunas Gasparaitis and Stephen Hanauer

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030402

    2. Sialyl-tn antigen expression in Crohn's colitis (pages 254–259)

      Alyssa Ta, Noam Harpaz, Carol Bodian, Alfred Roston, Lee Oberman, Anli Chen and Dr. Steven Itzkowitz

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030403

    3. The role of reactive oxygen metabolites in ulcerative colitis (pages 260–264)

      Dr. Ülkü Dagli, Mevhibe Balk, Doǧan Yücel, Aysel Ülker, Hülya Över, Gülsevim Saydam and Burhan Çahin

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030404

    4. An evaluation of utility measurement in Crohn's disease (pages 265–276)

      James C. Gregor, John W. D. McDonald, Neil Klar, Ronald Wall, Kenneth Atkinson, Binu Lamba and Dr. Brian G. Feagan

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030405

  3. Clinical Trials and Therapeutics

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Standards for trials of therapy in inflammatory bowel disease (pages 277–283)

      Dr. L. R. Sutherland, S. Hanauer and J. Scholmerich

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030406

    2. Issues in the development of practice guidelines for inflammatory bowel disease (pages 284–287)

      Dr. William J. Tremaine

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030407

  4. Clinical Reviews

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Interactions between chronic liver disease and inflammatory bowel disease (pages 288–302)

      Dr. Edward V. Loftus Jr., William J. Sandborn, Keith D. Lindor and Nicholas F. Larusso

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030408

  5. Basic Science Reviews

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Neuropeptides in inflammatory bowel disease: An update (pages 303–313)

      Max Reinshagen, Bernhard Egger, Frank Procaccino and Dr. Viktor E. Eysselein

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030409

  6. Controversies In IBD

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Antibiotics are effective therapy for Crohn's disease (pages 318–319)

      Dr. Mark A. Peppercorn

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030411

  7. Section Editors' Commentary

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Antibiotics are/are not effective therapy for Crohn's disease (page 320)

      Daniel H. Present and Peter A. Banks

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030412

  8. Selected Summaries

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Pouchitis risk: Flip the coin? (page 321)

      William J. Tremaine

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030413

    2. Corticotkopin keleasing by association? hormone-inflammation (pages 322–323)

      A. Christopher Stevens

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030415

    3. Burrill B. Crohn: Kindest regards (pages 323–324)

      Bret A. Lashner and Charles L. Bevins

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030416

  9. Announcements

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Controversies In IBD
    8. Section Editors' Commentary
    9. Selected Summaries
    10. Announcements
    1. Announcement (page 325)

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030417

SEARCH

SEARCH BY CITATION